Influence of MHC class II genotype on outcome of infection with hepatitis C virus

Lancet

Volumn 354, Issue 9196, 1999, Pages 2119-2124

  Thursz, Mark ^a   Yallop, Rhiannon ^a   Goldin, Robert ^a   Trepo, Christian ^b   Thomas, Howard C ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b HOSPICES CIVILS DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DQ ANTIGEN; HLA DR ANTIGEN; INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ADULT; ALLELE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HEREDITY; HISTOCOMPATIBILITY GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERSISTENT INFECTION; PRIORITY JOURNAL;

EID: 0033582107     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)91443-5     Document Type: Article

References (33)

1. Bismuth H, Samuel D, Castaing D, et al. The Paul Brousse liver transplant series 1989 to 1 992: new trends in the last four years. Clin Transplant 1992; 161-66.
2. Colantoni A, De Maria N, Fagiuoli S, Van Thiel DH. Liver transplantation in virus-induced chronic liver disease. Baillieres Clin Gastroenterol 1996; 10: 375-88.
3. Alter MJ, Margolis HS, Krawczynski K, et al. The natural history of community-acquired hepatitis C in the United States. N Engl J Med 1992;327: 1899-905.
4. Tong MJ, el-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1 995; 332: 1463-66.
5. Kenny-Walsh E. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin: Irish Hepatology Research Group. N Eng J Med 1999; 340: 1228-33.
6. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1 997; 349: 825-32.
7. Simmonds P, Holmes EC, Cha TA, et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Viral 1993; 74: 2391-99.
8. Simmonds P. Variability of the hepatitis C genome. In: Reesink HW, ed. Hepatitis C virus. 2nd edn. Basel: Garker, 1998: 38-63.
9. Jung MC, Diepolder HM, Pape GR. T cell recognition of hepatitis B and C viral antigens. Eur J Clin Invest 1994; 24: 641-50.
10. Hoffmann RM, Diepolder HM, Zachoval R, et al. Mapping of immunodominant CD4+ T lymphocyte epitopes of hepatitis C virus antigens and their relevance during the course of chronic infection. Hepatology 1995; 21: 632-38.
11. Diepolder HM, Gerlach JT, Zachoval R, et al. Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection. J Virol 1997; 71: 6011-19.
12. Cramp M, Rossol S, Carucci P, Williams R, Naumov N, Donaldson P. The influence of HLA class II allele DQB 10301 on HCV-specific T helper responses. J Hepatol 1998; 28 (suppl 1): 94.
13. Thursz MR, Kwiatkowski D, Allsopp CE, Greenwood BM, Thomas HC, Hill AV. Association between an MHC class II allele and clearance of hepatitus B virus in the Gambia. N Engl J Med 1995;332: 1065-69.
14. Alric L, Fort M, Izopet J, et al. Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection. Gastroenterology 1997; 113: 1675-81.
15. Tibbs C, Donaldson P, Underhill J, Thomson L, Manabe K, Williams R. Evidence that the HLA DQA103 allele confers protection from chronic HCV-infection in Northern European Caucasoids. Hepatology 1996; 24: 1342-45.
16. 6 Chen DF, Endres W, Kliem V, et al. No significant influence of HLA determinants on susceptibility to hepatitis C virus infection in Caucasian patients with end-stage renal disease. Liver 1996; 16: 384-89.
17. Cramp ME, Carucci P, Underhill J, Naoumov NV, Williams R, Donaldson PT. Association between HLA class II genotype and spontaneous clearance of hepatitis C viraemia. J Hepatol 1998; 29: 207-13.
18. Peano G, Menardi G, Ponzetto A, Fenoglio LM. HLA-DR5 antigen. A genetic factor influencing the outcome of hepatitis C virus infection? Arch Intern Med 1994; 154: 2733-36.
19. 9 Vine RL, Fortier C, Richarde! JP, et al. HLA antigens in patients with chronic hepatitis C. Tissue Antigens 1 995; 45: 356-61.
20. Czaja AJ, Carpenter H, Santrach PJ, Moore SB. DR human leucocyte antigens and disease severity in chronic hepatitis C. JHepatol 1996; 24: 666-73.
21. 1 Kuzushita N, Hayashi N, Katayama K, et al. Increased frequency of HLA DR1 3 in hepatitis C virus carriers with persistently normal ALT levels. J Med Viral 1996; 48: 1-7.
22. Congia M, Clemente MG, Dessi C, et al. HLA class II genes in chronic hepatitis C virus-infection and associated immunological disorders. Hepatology 1996; 24: 1338-41.
23. Hohler T, Gerken G, Notghi A, et al. MHC class II genes influence the susceptibility to chronic active hepatitis C. J Hepatol 1 997; 27: 259-64.
24. Zavaglia C, Bortolon C, Ferrioli G, et al. HLA tying in chronic type B, D and C hepatitis. J Hepatol 1996; 24: 658-65.
25. Aikawa T, Kojima M, Onishi H, et al. HLA DRB1 and DQB1 alleles and haplotypes influencing the progression of hepatitis C. J Med Virol 1996; 49: 274-78.
26. Higashi Y, Kamikawaji N, Suko H, Ando M. Analysis of HLA alleles in Japanese patients with cirrhosis due to chronic hepatitis C. J Gastroenterol Hepatol 1996; 11: 241-46.
27. Minton EJ, Smillie D, Neal KR, Irving WL, Underwood C, James V. Association between MHC class II alleles and clearance of circulating hepatitis C virus. J Infect Dis 1998; 178: 39-44.
28. Ishak KG, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-99.
29. Bunce M, O'Neill CM, Barnardo MC, et al. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 1995; 46: 355-67.
30. Diepolder HM, Zachoval R, Hoffmann RM, et al. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 1995; 346: 1006-07.
31. Almarri A, Batchelor JR. HLA and hepatitis B infection. Lancet 1994; 344: 1194-95.
32. McHutchison JG, Poynard T. Combination therapy with Interferon plus ribavirin for the initial treatment of chronic hepatitis C. Semin Liver Dis 1999; 19 (suppl 1): 57-65.
33. Thursz MR, Thomas HC, Greenwood BM, Hill AV. Heterozygote advantage for HLA class-II type in hepatitis B virus infection. Nat Genet 1997; 17: 11-12.